Answers are grounded in this paper and cite their sources.
Demonstrates a 3D tissue-on-a-chip model of long QT syndrome type 2 using gene-edited cardiac cells, suggesting a platform for testing pharmacological rescue strategies.
-edited hiPSC-CMs, revealing a possible mechanism of R531W mutation in LQTS2 pathophysiology. Following creation of a 3D LQTS2 tissue-on-a-chip, the tissues were extensively characterized, through analysis of calcium handling and response to β-agonist. Furthermore, attempted phenotypic rescue via pharmacological intervention of LQTS2 on a chip was investigated.
No takes yet. Share an insight, caveat, or question.
Veldhuizen et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: